Hubit Genomix, Inc.
Records under this name other than the patents Hubit Genomix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Hubit Genomix, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,827,719 | Method for Primary Prevention of Allergic Disorders During Infancy Through IgE-Class-Specific Immunosuppression Formerly held In force · High confidence | In force | High confidence | |
| US 7,901,874 | Methods for Identifying Agents for Preventing or Treating Proliferative Diseases, and for Inhibiting Extracellular Matrix or ALPHA1 Type IV Collagen Term ended Term ended Oct 10, 2026 · Medium confidence | Term ended | Term ended Oct 10, 2026 | Medium confidence |
| US 9,359,645 | Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1 Lapsed on the fee record Ended Jun 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2024 | From the USPTO record |